03:24 AM EDT, 05/17/2024 (MT Newswires) -- Michael F MacLean, Chief Financial Officer, on May 14, 2024, sold 75,000 shares in Avidity Biosciences ( RNA ) for $2,121,045. Following the Form 4 filing with the SEC, MacLean has control over a total of 44,093 shares of the company, with 44,093 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1599901/000095017024061258/xslF345X03/ownership.xml
Price: 29.40, Change: +0.68, Percent Change: +2.37